CanNordic a/s: Financial statements 2019
CVR: 33871902
Source: annual report 2019, Danish Business Authority
01/10/2018 – 30/09/2019
CanNordic a/s (CVR 33871902) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 211,131 and a net result of DKK -177,679 compared with DKK 200,388 the year before. That is a decrease of 63.5% compared with the year before. Equity in the 2019 report amounted to DKK -1,807,657.
- Gross Profit
- DKK 211,131
- Profit/Loss
- DKK -177,679
- Equity
- DKK -1,807,657
- Total Assets
- DKK 3,278,474
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 211 t. | -178 t. | -1.8 mio. | - |
| 2018 | - | 579 t. | 200 t. | -1.6 mio. | - |
| 2017 | - | -417 t. | -571 t. | -1.8 mio. | - |
| 2016 | - | -383 t. | -803 t. | -1.3 mio. | - |
| 2015 | - | -84 t. | -542 t. | -456 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
CanNordic a/s has published its annual report for 2018. Gross profit came to DKK 578,819, and the net result was DKK 200,388.
About CanNordic a/s
CanNordic a/s is a Danish company of the type Aktieselskab based in København Ø, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named GALAXA PHARMA ApS. The management consists of Lone Henriksen. The board consists of Gitte Henriksen, Jens Jørgen Hagelskjær and Lone Henriksen. The company is owned by CS MEDICA a/s. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK -100,395 and a net result of DKK -6,219,720 compared with DKK -4,881,640 the year before. Equity in the 2025 report amounted to DKK 4,298,968.